The FDA approved Neupro (Rotigotine Transdermal System) for the treatment of Parkinson's disease and restless leg syndrome.
Kevin Joseph, PharmD Candidate
Advertisement
Articles by Kevin Joseph, PharmD Candidate
Advertisement
Latest Updated Articles
- New FDA Actions: UCB's Neupro
Published: July 10th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5
